Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights.

Credit available for this activity expires: 02/19/27

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on the management of extensive-stage small cell lung cancer (ES-SCLC)?

Credit available for this activity expires: 2/20/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/quick-talk-es-sclc-what-community-clinicians-need-know-now-2026a100055m?ecd=bdc_podcast_libsyn_mscpedu

Clear communication builds trust in biosimilars.

Credit available for this activity expires: 2/19/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003245?ecd=bdc_podcast_libsyn_mscpedu

Early evidence for CAR T-cell therapy in lupus is compelling. Are you up-to-date?

Credit available for this activity expires: 2/9/26
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/car-t-cells-sle-new-frontier-autoimmunity-2026a10003ow?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date with the latest management for extensive-stage small cell lung cancer?

Credit available for this activity expires: 2/11/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/case-case-managing-es-sclc-real-world-through-patient-2026a10003ro?ecd=bdc_podcast_libsyn_mscpedu

How can AID close gaps in T2D care and help you personalize evidence-based AID for real-world practice?

Credit available for this activity expires: 1/30/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/utilizing-automated-insulin-delivery-close-gaps-type-2-2026a10002xh?ecd=bdc_podcast_libsyn_mscpedu

Shared decision-making isn't just a buzzword—it's the key to better adherence, fewer exacerbations, and improved quality of life for your patients.

Credit available for this activity expires: [01/30/27]
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/empowering-choices-moderate-severe-asthma-partnering-2026a10001d4?ecd=bdc_podcast_libsyn_mscpedu

Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases?

Credit available for this activity expires: 1/26/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?ecd=bdc_podcast_libsyn_mscpedu